Findings
========

Introduction
------------

Recent medical advances have resulted in remarkable improvements in the treatment of patients with chronic diseases, especially, in children \[[@B1]-[@B3]\]. However, end-stage renal disease (ESRD) practically affects every organ system, and thus, has a major impact, not only on mortality, but also on the quality of life (QOL) of the children suffering from the disease \[[@B4]\]. Systemic assessment of the health-related quality of life (HRQOL) in these children must be another essential process that may help promote a pediatric patient's successful transition into adulthood \[[@B5]\].

Recently, researchers have used pediatric HRQOL measures as a tool to evaluate healthcare services in an effort to improve the patient health and their well-being \[[@B6],[@B7]\]. For pediatric patients with ESRD, there has been an increasing clinical interest in their QOL, and their psychosocial adaptation \[[@B3],[@B5],[@B8]-[@B16]\].

To measure HRQOL, among the children with ESRD, we used several instruments, including the Pediatric Quality of Life Inventory™ (PedsQL™) Generic Core Scales \[[@B17]\], which contain general domains, but no ESRD-specific domains. Because of the need for a more appropriate measurement, the PedsQL™ End Stage Renal Disease Module \[[@B3]\] was developed as a PedsQL™ disease-specific module. The PedsQL™ was designed under a modular-approach \[[@B18]\] to cover both the generic and disease-specific domains. The PedsQL™ End Stage Renal Disease Module was developed through the focus groups, involving the healthcare providers, children, and parents; cognitive interviews; pre-testing; and field-testing \[[@B3]\].

The goal of this study is to assess the psychometric properties of the Korean translation of the PedsQL™ End Stage Renal Disease.

Methods
=======

Participants and settings
-------------------------

We performed a cross-sectional study of the Korean translations of the PedsQL End Stage Renal Disease Module, comparing the child self-reported and parent-proxy--reported HRQOL of the children with ESRD. The PedsQL 3.0 End Stage Renal Disease Module was administered from January 2011 through June 2011, one time each to the child and parent at four pediatric ESRD centers. Participants included children aged 2 to 18 years that received maintenance dialysis treatment or renal transplant care for at least 6 months and their parents. Child self-report includes ages 5--7, 8--12, and 13--18. Parent proxy-report includes ages 2--4 (toddler), 5--7 (young child), 8--12 (child), 13--18 (adolescent), and assesses the parent's perception of their child\'s HRQOL.

The human subject institutional review boards, at each institution, approved the study. Written parental informed consent and child assent were obtained before the enrollment of the subjects.

Measures
--------

### Translation - The Korean translations of the Pediatric Quality of Life Inventory™ (PedsQL™ 3.0) Version 3.0 End Stage Renal Disease Module

After we acquired permission from the original developer (Mapi Research Trust, on behalf of Dr. James W. Varni, copyright owner in the PedsQL™ ) for the original PedsQL 3.0 End Stage Renal Disease Module, the original English version of the PedsQL 3.0 End Stage Renal Disease Module was first translated into Korean, by a native Korean professional translator, who majored in English literature. Another bilingual translator backward-translated this revised Korean version of the PedsQL 3.0 End Stage Renal Disease Module into English. The correspondence between this back-translated version and the original English version was reviewed by the panel again. After considering the original, translated, and back-translated versions all together, we produced a pilot Korean version of the PedsQL 3.0 End Stage Renal Disease Module. Five children, from each age group participated in the pilot testing along with their parents. A researcher (MH or KS) measured the time taken to complete the questionnaire. Upon completing the questionnaire, the researcher interviewed each child and his or her parent, and the thought processes used in answering the questionnaire were deduced by cognitive interviewing \[[@B19]\]. A final version of the Korean version of the PedsQL™ 3.0 End Stage Renal Disease Module was produced after revising the pilot version using data obtained during pilot testing.

Measurements
------------

Parents completed a modified PedsQL 4.0 Generic Core Scales, PedsQL 3.0 End Stage Renal Disease Module that contained demographic information, including the child\'s date of birth, sex, parental age and education level, and patient\'s diagnosis age and duration.

### PedsQL 3.0 end stage renal disease module

The 34-item PedsQL 3.0 End Stage Renal Disease Module includes 7 scales. The scales are composed of both the child self-report and parent-proxy report formats for children aged 5 to 18 years, and a parent-proxy report format for children aged 2 to 4 years. The format, instructions, Likert response scale, and scoring method were identical to the PedsQL 4.0 Generic Core Scales, with higher scores indicating better HRQOL \[[@B5]\].

Statistical analysis
--------------------

The psychometric elements of the PedsQL 3.0 End Stage Renal Disease Module were examined in two parts: First, we assessed the data quality and internal consistency. Second, we compared PedsQL 3.0 End Stage Renal Disease Module and PedsQL 4.0 Generic Core Scales. Analyses were performed with SPSS 15.0 (SPSS, Chicago, IL).

Data quality was assessed by the mean, extent of ceiling and floor effects. Floor and ceiling effects between 1% and 15% were defined as optimal \[[@B20]\]. Internal consistency has been assessed with the use of Cronbach's alpha. While tests for construct validity usually compared PedsQL 4.0 Generic Core Scales, a spearman rank correlation test was used as a nonparametric approach \[[@B3]\], which is also used in most validation studies. Agreement between the child self-report and parent proxy-report was determined, through a two-way mixed effect model (absolute agreement, single measure) intraclass Correlation Coefficients (ICC) \[[@B3]\]. The ICC offers an index of absolute agreement, given that it takes into account the ratio between the subject variability and total variability \[[@B3],[@B21],[@B22]\]. ICCs are designated as ≤ 0.40 poor to fair agreement, 0.41--0.60 moderate agreement, 0.61--0.80 good agreement, and 0.81--1.00 excellent agreement \[[@B3]\].

Results
=======

A total of 92 children and adolescents (aged 2 to 18 years) with ESRD and their parents were enrolled in our study. Both the child self-report and parent-proxy report were available for the eighty six children aged 5 to 18 years. Most of the parent proxy reports in our study were completed by the mothers except one. The sample consisted of children receiving hemodialysis (n = 11; 12.0%), peritoneal dialysis (n = 44; 47.8%) and a renal transplant (n = 37; 40.2%) (Table [1](#T1){ref-type="table"}).

###### 

Patients Characteristics

           **Total No.(n,%)**                       **Total**    **Hemodialysis**   **Peritoneal Dialysis**   **Transplant**                   
  -------- -------------------------------------- ------------- ------------------ ------------------------- ---------------- ---- ------ ---- ------
           **Gender**                                                                                                                             
           Male                                        44              47.8                    5                   11.4        20   45.5   19   43.2
           Female                                      48              52.2                    6                   12.5        24   50.0   18   37.5
           **Age (mean ± SD)**                     12.1 ± 4.21     11.6 ± 5.26            12.6 ± 4.25          11.6 ± 3.84                     
           2-4 years: toddler                           6              6.5                     2                   33.3        3    50.0   1    16.7
           5-7 years: young child                       8              8.7                     1                   12.5        3    37.5   4    50.0
           8-12 years: child                           26              28.3                    1                   3.8         10   38.5   15   57.7
           13-18 years: adolescent                     52              56.5                    7                   13.5        28   53.8   17   32.7
           **Cause of ESRD**                                                                                                                      
  Child    CGN                                         37              40.2                    4                   10.8        21   56.8   12   32.4
           CPN                                          3              3.3                     0                   0.0         1    33.3   2    66.7
           Genetic Disease                             18              19.6                    2                   11.1        7    38.9   9    50.0
           Others                                      20              21.7                    5                   25.0        9    45.0   6    30.0
           Unknown cause                               14              15.2                    0                   0.0         6    42.9   8    57.1
           **Age at diagnosis of ESRD**                                                                                                           
           ≤ 4 years                                   28              30.4                    5                   17.9        7    25.0   16   57.1
           \> 4 years                                  64              69.6                    6                   9.4         37   57.8   21   32.8
           **Duration after diagnosis of ESRD**                                                                                                   
           \< 5 years                                  51              55.4                    6                   11.8        35   68.6   10   19.6
           ≥ 5 years                                   41              44.6                    5                   12.2        9    22.0   27   65.9
           **Father\'s age (mean ± SD)**           45.2 ± 5.03     44.3 ± 4.43            45.7 ± 5.18          44.8 ± 5.09                     
           \< 40 years                                 14              15.2                    2                   14.3        5    35.7   7    50.0
           ≥ 40 years                                  78              84.8                    9                   11.5        39   50.0   30   38.5
           **Father\'s educational level**                                                                                                        
           High school or below                        44              47.8                    5                   11.4        19   43.2   20   45.5
           College or over                             48              52.2                    6                   12.5        25   52.1   17   35.4
           **Mother\'s age (mean ± SD)**           42.5 ± 4.77     40.8 ± 4.14            43.3 ± 5.18          41.9 ± 4.28                     
  Parent   \< 40 years                                 26              28.3                    5                   19.2        8    30.8   13   50.0
           ≥ 40 years                                  66              71.7                    6                   9.1         36   54.5   24   36.4
           **Mother\'s educational level**                                                                                                        
           High school or below                        53              57.6                    7                   13.2        25   47.2   21   39.6
           College or over                             39              42.4                    4                   10.3        19   48.7   16   41.0
           **Parental marital status**                                                                                                            
           Married                                     82              89.1                    9                   11.0        41   50.0   32   39.0
           Divorced, Separated                         10              10.9                    2                   20.0        3    30.0   5    50.0
           **Total**                                   92             100.0                   11                   12.0        44   47.8   37   40.2

CGN, chronic glomerulonephritis; CPN, chronic pyelonephritis; ESRD, end-stage renal disease.

The percentage of missing item responses was less than 1.1% for the child self-report and parent proxy report. The average scores of the parent proxy report were 45.4-72.3 and the child self-report were 57.5-71.4. Ceiling effects occurred between 1.1% and 14.1% and floor effects occurred between 4.3% and 14.1%; thus, these effects did not represent a limitation of the PedsQL End Stage Renal Disease Module.

Internal consistency reliability coefficients for the PedsQL 3.0 End Stage Renal Disease Module are listed in Table [2](#T2){ref-type="table"}. All parent-proxy report scales, except for one, exceeded the minimum reliability standard of 0.70, and four child self-report scales exceeded the minimum reliability standard.

###### 

Scale Descriptives for the PedsQL™ 3.0 ESRD module

                                   **Mean**   **SD**   **Ceiling**   **Floor**   **Cronbach\'s alpha**
  ------------------------------- ---------- -------- ------------- ----------- -----------------------
  **Parent-proxy report**                                                                   
  General Fatigue                    47.0     22.31        3.3          2.2              0.88
  About My Kidney Disease            62.8     19.60        5.4          1.1              0.83
  Treatment Problems                 65.0     18.55        3.3          1.1              0.65
  Family and Peer Interaction        52.5     22.76        5.4          4.3              0.81
  Worry                              45.4     22.83        1.1          3.3              0.92
  Perceived Physical Appearance      51.5     24.74        6.5          4.3              0.70
  Communication                      72.3     19.70       14.1          1.1              0.91
  **Child-self report**                                                                     
  General Fatigue                    57.5     21.22        4.3          1.1              0.83
  About My Kidney Disease            67.7     18.57        6,5          2.2              0.77
  Treatment Problems                 67.2     18.50        7,6          1.1              0.57
  Family and Peer Interaction        65.1     22.24       12.0          1.1              0.70
  Worry                              63.2     20.77        5.4          2.2              0.90
  Perceived Physical Appearance      59.5     25.46       12.0          2.2              0.68
  Communication                      71.4     21.19       14.1          1.1              0.87

Intercorrelations, between the Generic Core Scales and summary scores with the PedsQL 3.0 End Stage Renal Disease Module, are listed in Table [3](#T3){ref-type="table"}. The majority of intercorrelations were in the medium to large range, supporting the construct validity.

###### 

Correlation Coefficients among PedsQL Scales for the Child Self-Report and Parent-Proxy Report for the ESRD Sample

                           **Child Self-Report**   **Parent-Proxy Report**                                                                                                                                     
  ----------- ------------ ----------------------- ------------------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------
  Child                                                                                                                                                                                                         
  GF          1                                                                                                                                                                                                 
  KD          0.45^\*\*^   1                                                                                                                                                                                    
  TP          0.18         0.27^\*\*^              1                                                                                                                                                            
  F/PI        0.40^\*\*^   0.29^\*\*^              0.56^\*\*^                1                                                                                                                                  
  W           0.36^\*\*^   0.41^\*\*^              0.38^\*\*^                0.63^\*\*^   1                                                                                                                     
  PA          0.30^\*\*^   0.61^\*\*^              0.40^\*\*^                0.49^\*\*^   0.52^\*\*^   1                                                                                                        
  C           0.36^\*\*^   0.28^\*\*^              0.24^\*^                  0.48^\*\*^   0.34^\*\*^   0.38^\*\*^   1                                                                                           
  Parent\'s                                                                                                                                                                                                     
  GF          0.57^\*\*^   0.38^\*\*^              0.31^\*\*^                0.47^\*\*^   0.36^\*\*^   0.36^\*\*^   0.31^\*\*^   1                                                                              
  KD          0.36^\*\*^   0.54^\*\*^              0.36^\*\*^                0.41^\*\*^   0.35^\*\*^   0.38^\*\*^   0.21^\*^     0.61^\*\*^   1                                                                 
  TP          0.19         0.23^\*^                0.60^\*\*^                0.42^\*\*^   0.24^\*^     0.32^\*\*^   0.14         0.43^\*\*^   0.56^\*\*^   1                                                    
  F/PI        0.51^\*\*^   0.19                    0.32^\*\*^                0.53^\*\*^   0.44^\*\*^   0.25^\*^     0.32^\*\*^   0.63^\*\*^   0.53^\*\*^   0.44^\*\*^   1                                       
  W           0.34^\*\*^   0.21^\*^                0.21^\*^                  0.34^\*\*^   0.41^\*\*^   0.152        0.24^\*^     0.42^\*\*^   0.47^\*\*^   0.41^\*\*^   0.56^\*\*^   1                          
  PA          0.40^\*\*^   0.36^\*\*^              0.37^\*\*^                0.38^\*\*^   0.38^\*\*^   0.51^\*\*^   0.27^\*^     0.54^\*\*^   0.60^\*\*^   0.51^\*\*^   0.63^\*\*^   0.51^\*\*^   1             
  C           0.35^\*\*^   0.28^\*\*^              0.24^\*^                  0.38^\*\*^   0.34^\*\*^   0.32^\*\*^   0.52^\*\*^   0.44^\*\*^   0.37^\*\*^   0.24^\*^     0.42^\*\*^   0.36^\*\*^   0.41^\*\*^   1
  Child                                                                                                                                                                                                         
  PH          0.51^\*\*^   0.50^\*\*^              0.28^\*^                  0.53^\*\*^   0.47^\*\*^   0.49^\*\*^   0.34^\*\*^   0.46^\*\*^   0.42^\*\*^   0.21         0.35^\*\*^   0.29^\*\*^   0.33^\*\*^   0.34^\*\*^
  PsyH        0.51^\*\*^   0.45^\*\*^              0.48^\*\*^                0.64^\*\*^   0.58^\*\*^   0.48^\*\*^   0.48^\*\*^   0.50^\*\*^   0.45^\*\*^   0.42^\*\*^   0.47^\*\*^   0.41^\*\*^   0.40^\*\*^   0.47^\*\*^
  EF          0.42^\*\*^   0.45^\*\*^              0.49^\*\*^                0.59^\*\*^   0.61^\*\*^   0.54^\*\*^   0.41^\*\*^   0.44^\*\*^   0.44^\*\*^   0.45^\*\*^   0.32^\*\*^   0.37^\*\*^   0.41^\*\*^   0.45^\*\*^
  SF          0.44^\*\*^   0.40^\*\*^              0.40^\*\*^                0.59^\*\*^   0.49^\*\*^   0.48^\*\*^   0.40^\*\*^   0.42^\*\*^   0.41^\*\*^   0.35^\*\*^   0.39^\*\*^   0.26^\*^     0.32^\*\*^   0.41^\*\*^
  SchH        0.44^\*\*^   0.28^\*\*^              0.33^\*\*^                0.44^\*\*^   0.38^\*\*^   0.20         0.40^\*\*^   0.41^\*\*^   0.30^\*\*^   0.28^\*\*^   0.48^\*\*^   0.40^\*\*^   0.27^\*^     0.34^\*\*^
  Parent\'s                                                                                                                                                                                                     
  PH          0.34^\*\*^   0.31^\*\*^              0.23^\*^                  0.31^\*\*^   0.29^\*\*^   0.23^\*^     0.10         0.53^\*\*^   0.58^\*\*^   0.29^\*\*^   0.47^\*\*^   0.34^\*\*^   0.49^\*\*^   0.34^\*\*^
  PsyH        0.49^\*\*^   0.29^\*\*^              0.31^\*\*^                0.42^\*\*^   0.36^\*\*^   0.28^\*\*^   0.32^\*\*^   0.57^\*\*^   0.63^\*\*^   0.37^\*\*^   0.56^\*\*^   0.44^\*\*^   0.51^\*\*^   0.46^\*\*^
  EF          0.38^\*\*^   0.36^\*\*^              0.35^\*\*^                0.37^\*\*^   0.46^\*\*^   0.33^\*\*^   0.29^\*\*^   0.53^\*\*^   0.61^\*\*^   0.35^\*\*^   0.42^\*\*^   0.37^\*\*^   0.49^\*\*^   0.43^\*\*^
  SF          0.44^\*\*^   0.15                    0.22^\*^                  0.34^\*\*^   0.19         0.24^\*^     0.24^\*^     0.48^\*\*^   0.53^\*\*^   0.32^\*\*^   0.52^\*\*^   0.30^\*\*^   0.45^\*\*^   0.36^\*\*^
  SchH        0.45^\*\*^   0.24^\*^                0.23^\*^                  0.37^\*\*^   0.29^\*\*^   0.15         0.30^\*\*^   0.45^\*\*^   0.48^\*\*^   0.30^\*\*^   0.49^\*\*^   0.46^\*\*^   0.38^\*\*^   0.39^\*\*^

Abbreviations: *GF*, general fatigue; *HD*, about my kidney disease; *TP*, treatment problems; *F/PI*, family and peer interaction; *W*, worry; *PA*, perceived physical appearance; *C*, communication; *PH*, physical functioning; *PsyH*, psychosocial functioning; *EF*, emotional functioning; *SF*, social functioning; *SchH*, school functioning.

\*p \< 0.05, \*\*p \< 0.01.

Table [4](#T4){ref-type="table"} lists ICCs between the children self-report and parent proxy report. ICCs are in the moderate or good agreement range for 11 of 12 PedsQL Scales and in the poor agreement range for 1 of 12 PedsQL Scales. The greatest overall agreement is found on the School function (0.73) and the lowest agreement is found on the Worry (0.35).

###### 

ICCs Between Child Self-Report and Parent-Proxy Report for the PedsQL 4.0 Generic Core Scales and PedsQL 3.0 ESRD Module for ESRD Sample

  **Scale**                       **ICC**
  ------------------------------- ------------
  Total ESRD score                0.57^\*\*^
  General Fatigue                 0.49^\*\*^
  About My Kidney Disease         0.52^\*\*^
  Treatment Problems              0.60^\*\*^
  Family and Peer Interaction     0.42^\*\*^
  Worry                           0.35^\*^
  Perceived Physical Appearance   0.48^\*\*^
  Communication                   0.52^\*\*^
  Physical Health                 0.44^\*\*^
  Psychosocial Health             0.58^\*\*^
  Emotional Functioning           0.49^\*\*^
  Social Functioning              0.45^\*\*^
  School Functioning              0.73^\*\*^

\*p \< 0.01, \*\*p \< 0.001.

Discussion
==========

We have translated and adapted the original 34-items of PedsQL 3.0 End Stage Renal Disease Module into a Korean version. The Korean, as well as the English version of the PedsQL 3.0 End Stage Renal Disease Module, represents a comprehensive, brief and low time consuming instrument to assess the quality of care of pediatric ESRD patients.

According to the recent Consensus-based Standards (COSMIN) of assessing the methodological quality of patient reported measures \[[@B23]\], reliability, validity and responsiveness must be evaluated before these instruments can be used for research and development. Thus, we needed to first look at the content, criteria and construct validity of the PedsQL 3.0 End Stage Renal Disease Module, since this study may point out critical issues.

The response rate was acceptable since no reminders were delivered. A large proportion of the responders answered \>90% of theitems, suggesting good face validity. In addition, the PedsQL 4.0 Generic Core Scales and the PedsQL 3.0 End Stage Renal Disease Module showed minimal missing values in the current study, supporting feasibility \[[@B3]\]. The validation analyses revealed acceptable floor and ceiling effects, and an acceptable internal consistency for the seven proposed subscales and a reasonable good model fit of the proposed factorial structures.

Our findings showed that the instrument had reasonably good internal's reliability, among the ESRD patients; the results of the assessment of internal consistency showed that the PedsQL 3.0 End Stage Renal Disease Module appeared to measure what it is supposed to. For the PedsQL 3.0 End Stage Renal Disease Module, six of seven parent-proxy report scales, and five of seven child self-report scales exceeded the minimum coefficient standard of 0.70. Scales that met the minimum coefficient standard of 0.70 may be used to examine the specific domains of HRQOL, as well as subgroup differences. In the current study, only the Cronbach's alpha for the Treatment Problems Scale for child self-report was problematic, which is similar to the original US study \[[@B3]\]. As noted by Goldstein et al. \[[@B3]\], the Treatment Problems Scale is not conceptually an HRQOL scale as such, but rather a treatment barriers scale, and in the adult patients, higher perceived barrier scores were significantly associated with lower self-reported adherence and poorer prescription refill rates. However, parents provided more prompts to their children to take medication if their children had a greater number of problems \[[@B24]\]. That is, a remembrance to take medications that is an item of Treatment Problems Scale is affected by their parents in Korea, the other three treatments barrier items are affected by their self. The other child self-report scales are over or near 0.70. These items were shown to be selective and non-redundant, which resulted in very satisfactory results for Cronbach's alpha \[[@B25]\].

In this study, children with ESRD and their parents were shown to have poor to good agreement at most. These results indicate that the information provided by proxy respondents is not always equivalent to that reported by the patient. Child age and parental distress can affect the children's and parents' perceptions of the health and well-being of the child \[[@B3]\].

The present study has several limitations. Although our recruitment strategy enabled us to generalize beyond a clinical sample, and was comparable to the other samples, in terms of age and sex, the sample was a purposive one. Further, information for nonparticipants was not available, and in addition, the sample size for young children with ESRD was small and the sample size of older children was large, which may limit generalizability. Although the number of patients used in this study was lower (92 patients), these enrolled patients consisted of about 31% of the total pediatric ESRD patients in our country, the so called 'The Korea Pediatric CKD registry', which has been operated from 2007 to 2010. A total of 294 patients (hemodialysis: 27 patients, peritoneal dialysis: 99 patients, renal transplantation: 168) were registered to that registry. At present, the most common causes of ESRD in adults are diabetes mellitus (DM) and hypertension, but, in children, glomerulonephritis and chronic pyelonephritis are most common causes, similar to that of the previous reports. Although the prevalence rate of DM and hypertension in children are markedly increasing, these causes cannot develop ESRD within the childhood period because of long duration for progression to ESRD. Therefore, the incident rate of ESRD in children is extremely rare (only 4 children/million), and adolescent patients tend to be relatively more than young children during childhood period.

This study demonstrated that the PedsQL 3.0 End Stage Renal Disease Module was a feasible, reliable, and a valid instrument to assess the specific HRQOL in children with ESRD, and the PedsQL 3.0 End Stage Renal Disease Module represented a realistic and relevant landscape of the components relevant for the future evaluation of Korean chronic care.
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